HRT Types and Delivery

FDA-Approved vs. Compounded Hormones: What’s the Difference?

October 6, 2026

FDA-Approved vs. Compounded Hormones is a common question for people considering hormone therapy. This article explains the main differences in regulation, manufacturing, labeling, and evidence so you can have a clearer conversation with your clinician.

Key takeaways
FDA-approved hormone products undergo formal review for safety, effectiveness, and consistent manufacturing; compounded hormones do not.
Compounders may fill specific patient needs (allergies, unique doses), but quality, consistency, and evidence vary more than with approved products.
Decisions about hormone treatment should balance benefits, risks, available evidence, and trusted clinical guidance—talk with your healthcare provider.

What “FDA-approved” means

When a hormone product is FDA-approved, the manufacturer submitted data to the U.S. Food and Drug Administration showing the product’s safety, effectiveness, and manufacturing quality for specific uses. The FDA reviews clinical trials, chemistry and manufacturing controls, labeling, and post-marketing safety plans before granting approval. Approved products are produced in regulated facilities and must follow current Good Manufacturing Practices (cGMP).

Key elements of FDA review

Clinical evidence: Controlled studies that test whether the hormone produces the expected benefits and measure side effects.
Manufacturing quality: Facility inspections and documentation that the product is made consistently and is pure and potent.
Labeling and instructions: Standardized prescribing information that lists approved uses, dosing ranges (for prescribers), warnings, and known risks.
Post-market monitoring: Systems to report and track adverse events after approval.

FDA approval provides a predictable level of evidence and manufacturing oversight. This does not mean an approved product is risk-free—approved hormones carry known risks and side effects that are described in the official labeling and professional guidance from groups like ACOG and The North American Menopause Society (NAMS).

What “compounded” hormones are

Compounded hormones are custom-made preparations mixed by pharmacists or specialized compounding pharmacies to meet an individual patient’s needs. In the United States, compounding is regulated differently from mass-produced drugs. Some compounding happens in local pharmacies (503A compounding) and some in larger outsourcing facilities (503B), each with different regulatory expectations under the Federal Food, Drug, and Cosmetic Act.

Common reasons clinicians and patients choose compounded hormones

Allergies to fillers or preservatives found in an approved product.
Need for a dosage form or dose not commercially available (for example, a very small or specific dose).
Preference for a particular delivery method that isn’t available as an approved product.
Shortages of approved products may prompt temporary compounding.

Compounded preparations can be important in specific, individualized situations. However, compounding pharmacies are not required to provide the same level of pre-market clinical evidence or standardized labeling that FDA-approved manufacturers must provide.

Regulatory differences: FDA, state boards, and standards

The legal and regulatory landscape around compounding is layered.

Federal vs. state oversight

FDA: Oversees mass-manufactured drugs and has authority over large outsourcing compounding facilities (503B). FDA inspects and can take action against pharmacies that produce unsafe or misbranded products.
State boards of pharmacy: License and inspect local pharmacies and regulate practice standards for compounding at the state level.
United States Pharmacopeia (USP): Publishes quality standards (USP <795>, <797>, <800>) that many pharmacies aim to follow for sterile and non-sterile compounding.

What the different regulatory pathways mean for patients

FDA-approved products: Reviewed for safety and efficacy; consistent manufacturing; labeling and post-market surveillance.
503A compounding: Patient-specific prescriptions compounded by local pharmacies; regulated by state boards; generally not required to undergo FDA pre-market review.
503B outsourcing facilities: Can produce larger quantities and register with FDA; expected to follow stricter manufacturing standards and are subject to FDA inspections, but still do not have the same clinical-review process as approved drugs.

Quality, potency, and consistency: what the evidence shows

Studies and inspections have found greater variability in compounded products compared with FDA-approved products. Problems reported to regulators have included incorrect hormone strength, contamination, and inconsistent release from certain dosage forms.

Potency and dosing concerns

An FDA-approved product must meet strict specifications for potency—meaning the amount of active hormone is within a stated range. Compounded products have shown more variation in potency, which can affect symptom control and safety. Variability is a particular concern with compounded hormones delivered by creams, gels, troches, or pellets where dose uniformity and absorption can be unpredictable.

Labeling and informed consent

Approved products come with standardized prescribing information that summarizes clinical trial data and known risks. Compounded hormones typically lack such formal labeling and may not have consistent, evidence-based guidance about expected benefits and risks. If you receive a compounded product, a clear discussion with your clinician about why it’s being used and what to expect is important.

Evidence: clinical trials and safety data

FDA-approved hormone therapies have been studied in clinical trials of varying size and quality, providing structured evidence about benefits and risks for specific indications (for example, menopausal symptom relief, prevention of bone loss in certain situations). Compounded products generally lack large-scale randomized trials, so evidence about their effectiveness and safety is limited or absent.

Some patients ask about “bioidentical” hormones. If you want information on terminology and how bioidentical is used in practice, see what bioidentical hormones means.

Specific considerations: pellet therapy and other delivery options

Pellet therapy is one form of hormone delivery that is often compounded and inserted under the skin. Some clinics offer commercially manufactured pellets, while others use compounded pellets made by pharmacies. There is ongoing discussion in the medical community about pellet safety and evidence.

For a review of the current evidence and safety data on pellet therapy, see hormone pellet evidence and safety.

What to discuss with your clinician about pellets and other options

Is the pellet product FDA-approved or compounded? If compounded, where is it made and what quality checks are done?
What are the known risks and potential long-term effects for your situation?
How will dosing be monitored, and what follow-up is planned?

If you are considering care through telehealth or an online clinic, it’s also wise to know what systems they use to prescribe and dispense hormones—this is part of comparing online HRT providers.

Benefits and risks: a balanced view

Hormone therapy, whether with FDA-approved or compounded products, aims to relieve symptoms (such as hot flashes, night sweats, vaginal dryness) or manage hormone-related health issues. Benefits and risks depend on the hormone type, dose, route of delivery, patient age, medical history, and individual factors.

Potential benefits

Relief of menopausal vasomotor symptoms (hot flashes, night sweats).
Improved vaginal dryness and sexual comfort with appropriate local therapies.
Possible positive effects on sleep, mood, and quality of life in some people.

Potential risks and side effects

Short-term side effects: breast tenderness, bloating, mood changes.
Longer-term risks depend on type and combination of hormones and personal health history; these can include cardiovascular risks and effects on breast and endometrial tissue. Professional guidance from organizations such as ACOG and NAMS should guide individualized risk assessment.
Additional uncertainty with compounded products: variable potency, contamination risk, unknown absorption—factors that could worsen side effects or reduce effectiveness.

Who should not use hormone therapy without careful assessment

People with a history of certain cancers (for example, some breast cancers) or unexplained vaginal bleeding should have evaluation and specialist input.
People with active or recent blood clots, certain heart disease, or liver disease need careful assessment and alternative strategies may be recommended.
Pregnant or breastfeeding people should not use some forms of hormone therapy aimed at menopausal symptom relief.

When compounded hormones may be reasonable

There are legitimate situations where compounded hormones are clinically reasonable:

True allergy to an inactive ingredient in an approved product.
A patient needs a very specific dose or delivery method not available commercially and the prescriber documents medical necessity.
Shortages of approved products that leave no suitable commercial alternative.

When compounding is chosen, ask about the pharmacy’s quality systems, whether they follow USP standards, if they are inspected by state boards or FDA (for 503B), and whether they provide certificate of analysis or testing information.

Practical tips for patients

Ask your clinician whether a prescribed hormone is FDA-approved or compounded, and why that choice was made.
If a product is compounded, request details about the compounding pharmacy’s credentials, quality checks, and sterility/potency testing.
Review the expected benefits, known risks, and monitoring plan. Ask how outcomes and side effects will be tracked.
Keep a record of the product name, ingredients, batch number (if available), and where it was dispensed. Report any unexpected side effects promptly.
If you use telehealth or mail-order services, verify licensing, prescribing practices, and how the pharmacy dispenses the medication—see comparing online HRT providers for points to consider.

Frequently Asked Questions

Are compounded hormones illegal?

No. Compounded hormones are legal when made to meet an individual patient’s need and when pharmacies follow applicable state and federal regulations. However, compounded products are regulated differently than FDA-approved drugs and are not subject to the same pre-market review for safety and effectiveness.

Is “bioidentical” the same as compounded?

Not always. “Bioidentical” refers to hormones with the same molecular structure as human hormones. Some FDA-approved products are bioidentical, and some compounded products are marketed as bioidentical. The term can be used inconsistently; for clarity see what bioidentical hormones means.

Do compounded hormones carry more risk than FDA-approved products?

Compounded hormones can carry additional uncertainty because they often lack the standardized testing and clinical trial data required for FDA approval. Reported problems have included variable potency and contamination. That said, when compounding is done by reputable pharmacies with good quality controls and for clear medical reasons, it may be an appropriate option.

How do I know if a compounded product is high quality?

Ask the prescriber or pharmacy for information: whether they follow USP compounding standards, if they are a registered 503B outsourcing facility inspected by FDA, whether they provide certificates of analysis, and how they verify potency and sterility for sterile products.

Should I switch if I’m already using a compounded hormone?

Any decision to switch should be made with your clinician. Consider the reason you were prescribed a compounded product, whether an approved alternative exists, and the quality and monitoring you are currently receiving. Do not stop or change therapies without medical advice.

Conclusion

FDA-approved and compounded hormones serve different roles. FDA-approved products benefit from formal review, standardized manufacturing, and clinical trial evidence. Compounded hormones can meet specific individual needs but have more variability in quality, potency, and evidence. Discuss the options, expected benefits, known risks, and follow-up plans with your healthcare provider so you can make an informed choice that fits your medical history and goals.

Medical disclaimer: This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Hormone therapy is not right for everyone. Always talk to your doctor or another qualified healthcare provider about your symptoms, health history and treatment options before starting, stopping or changing any medication.